This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Lakehead University directory, so their courses may be missing. Find their university profile.
Research
Latest papers
Urea-based lysophosphatidic acid receptor 1 antagonists as potential migrastatics for triple-negative breast cancer.
Bioorganic chemistry · 2026 · senior author
Multifunctional RNA G-Quadruplex Ligand for Integrated Photodynamic Therapy and Oncoprotein Translation Inhibition in Cancer Cells.
Journal of medicinal chemistry · 2026
"Several birds with one stone": exploring the potential of AI methods for multi-target drug design.
Molecular diversity · 2025
Latest funding
- $39,451
A Microwave System for Medicinal Chemistry and Radiochemistry Research
NSERC · 2021 · Principal investigator
- $144,000
Development of Radio-Fluorination Methods and Novel Molecular Imaging Agents
NSERC · 2019 · Principal investigator
- $12,500
Development of Radio-Fluorination Methods and Novel Molecular Imaging Agents
NSERC · 2019 · Principal investigator
16 publications.
Urea-based lysophosphatidic acid receptor 1 antagonists as potential migrastatics for triple-negative breast cancer.
Liu W, Mousa AAK, Dayer G, Hopkins AM, Campbell M, Mao Y, Jiang ZH, Lees SJ, Ramachandran R, Hou J
Multifunctional RNA G-Quadruplex Ligand for Integrated Photodynamic Therapy and Oncoprotein Translation Inhibition in Cancer Cells.
Long W, Zheng BX, Wang YK, She MT, Zeng YX, Zheng YY, Zheng WD, Zhang KX, Lin DM, Mao Y, Hou J, Wong WL
"Several birds with one stone": exploring the potential of AI methods for multi-target drug design.
Mukaidaisi M, Ahmed M, Grantham K, Al-Jumaily A, Dedhar S, Organ M, Tchagang A, Hou J, Ahmed SE, Dividino R, Li Y
Cancer Cells in Sleep Mode: Wake Them to Eliminate or Keep Them Asleep Forever?
Liu W, Kovacs AH, Hou J
Design, Synthesis, and Preclinical Evaluation of a High-Affinity 18F-Labeled Radioligand for Myocardial Growth Hormone Secretagogue Receptor Before and After Myocardial Infarction.
Sullivan R, Hou J, Yu L, Wilk B, Sykes J, Biernaski H, Butler J, Kovacs M, Hicks J, Thiessen JD, Dharmakumar R, Prato FS, Wisenberg G, Luyt LG, Dhanvantari S
Lysophosphatidic Acid Receptor 1 (LPA1) Antagonists as Potential Migrastatics for Triple Negative Breast Cancer.
Liu W, Mousa AAK, Hopkins AM, Wu YF, Thu KL, Campbell M, Lees SJ, Ramachandran R, Hou J
Integrating transformers and many-objective optimization for drug design.
Aksamit N, Hou J, Li Y, Ombuki-Berman B
Synthesis and Evaluation of [18F]AlF-NOTA-c-DVAP: A Novel PET Probe for Imaging GRP78 in Cancer.
Huang J, Bai L, Shi D, Jiang W, Chen P, Dong Y, Zhang X, Peng J, Hou J, Lu Y, Huang X, Tang G, Huang S
Can machine learning 'transform' peptides/peptidomimetics into small molecules? A case study with ghrelin receptor ligands.
Liu W, Hopkins AM, Yan P, Du S, Luyt LG, Li Y, Hou J
Bioinformatic assay reveal the potential mechanism of Guizhi-Shaoyao-Zhimu decoction against rheumatoid arthritis and mild-to-moderate COVID-19.
Xu Y, Huang Z, Wu G, Jin F, Lin S, Zhang C, Zheng J, Liu W, Hou J, Lu YJ
A Microwave System for Medicinal Chemistry and Radiochemistry Research
Principal investigators: Hou, Jinqiang
Development of Radio-Fluorination Methods and Novel Molecular Imaging Agents
Principal investigators: Hou, Jinqiang
Keywords: radiochemistry; molecular imaging; fluorination; positron emission tomography; asymmetric synthesis; medicinal chemistry; drug design; fluorine-18; computational modelling; synthetic chemistry
Development of Radio-Fluorination Methods and Novel Molecular Imaging Agents
Principal investigators: Hou, Jinqiang
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Rithwik Ramachandran and Jinqiang Hou: 3 shared papers
- Jinqiang Hou and Yifeng Li: 3 shared papers
- Savita Dhanvantari and Michael Kovacs: 2 shared papers
- Savita Dhanvantari and Jinqiang Hou: 2 shared papers
- Rithwik Ramachandran and Michael Campbell: 2 shared papers
- Jinqiang Hou and Michael Campbell: 2 shared papers
- Yifeng Li and Beatrice Ombuki-Berman: 2 shared papers
- Shoukat Dedhar and Jinqiang Hou: 1 shared paper
- Shoukat Dedhar and Yifeng Li: 1 shared paper
- Shoukat Dedhar and Renata Dividino: 1 shared paper
- Savita Dhanvantari and Rithwik Ramachandran: 1 shared paper
- Rithwik Ramachandran and Zi-Hua Jiang: 1 shared paper
- Michael Kovacs and Jinqiang Hou: 1 shared paper
- Zi-Hua Jiang and Jinqiang Hou: 1 shared paper
- Zi-Hua Jiang and Michael Campbell: 1 shared paper
- Jinqiang Hou and Beatrice Ombuki-Berman: 1 shared paper
- Jinqiang Hou and Shan Du: 1 shared paper
- Jinqiang Hou and Renata Dividino: 1 shared paper
- Yifeng Li and Shan Du: 1 shared paper
- Yifeng Li and Renata Dividino: 1 shared paper
- Chemistry
- Physiology and Pharmacology
- Department of Computer Science
- Medical Biophysics
- Computer Science
- Medicine
- Communication and media studies
- Other
Co-authors at Lakehead University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Yifeng Li
Department of Computer Science
3 shared papers, latest 2025
Rithwik Ramachandran
Physiology and Pharmacology
3 shared papers, latest 2026
Michael Campbell
Chemistry
2 shared papers, latest 2026
Savita Dhanvantari
Medical Biophysics
2 shared papers, latest 2024
Beatrice Ombuki-Berman
Computer Science
1 shared papers, latest 2024
Renata Dividino
Communication and media studies
1 shared papers, latest 2025
Shan Du
Okanagan - Department of Computer Science, Mathematics, Physics and Statistics
1 shared papers, latest 2023
Shoukat Dedhar
Biochemistry and Molecular Biology
1 shared papers, latest 2025
Michael Kovacs
Medicine
1 shared papers, latest 2024
Zi-Hua Jiang
Chemistry
1 shared papers, latest 2026
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.